Most cannabis users ignore cannabinoid content when assessing health risks

This study examined how young adult college students perceive the health risks and benefits of cannabis products based on their cannabinoid content (THC and CBD ratios) and how they're consumed (flower versus edibles). Using two parallel experiments with over 2,000 participants, researchers randomly assigned students to evaluate different cannabis products with varying potencies. The findings reveal a surprisingly limited distinction: only CBD-dominant flower products were perceived as significantly healthier than other products, while all other comparisons—between THC-dominant and balanced strains, or across edible products—showed no meaningful differences in perceived benefits, risks, or purchase intentions.

The study is particularly notable for what it reveals about cannabis consumer awareness and decision-making. Despite widespread availability of different cannabinoid ratios and consumption methods in legal cannabis markets, young adults appear to make minimal health-related distinctions between these options. These perceptions were consistent regardless of whether participants were current cannabis users or not, and didn't change based on their tolerance levels. This suggests that many consumers may not be informed by or responsive to cannabinoid content when evaluating health consequences.

For cannabis industry professionals, public health communicators, and policymakers, these findings highlight a significant gap between product diversity and consumer understanding. The research underscores the need for clearer, more targeted education efforts that help young adults understand the actual health implications of different cannabinoid profiles and consumption methods. Without such communication, marketing claims about health benefits or risks may have little impact on how people actually perceive and choose cannabis products.